«Colossus with feet of clay»: a case report
- 作者: Adasheva T.V.1, Gubernatorova E.E.1, Boltikova V.V.1, Akhmedyarova L.B.2,3, Bagatyrova K.M.1
-
隶属关系:
- Russian University of Medicine of the Ministry of Healthcare of Russia
- Reaviz Medical University
- Hospital of Centrosoyuz of the Russian Federation
- 期: 卷 11, 编号 8 (2025)
- 页面: 86-95
- 栏目: CLINICAL CASES
- URL: https://journals.eco-vector.com/2412-4036/article/view/696089
- DOI: https://doi.org/10.18565/therapy.2025.8.86-95
- ID: 696089
如何引用文章
详细
The incidence of drug-induced diseases increases every year. The number of cases of off-label drug use is growing too. Current article presents a clinical observation of a bodybuilder with hereditary thrombophilia. It describes in detail the effects of testosterone medications on various organs and systems (cardiovascular, hematopoiesis, kidneys, prostate, hemostasis), analyzing side effects using a specific example. Mechanisms of renal damage associated with a high-protein diet are discussed. This clinical case illustrates the challenges of managing patients with drug-induced diseases, emphasizing the importance of awareness by physicians about systemic effects of testosterone-containing medications and high-protein diet.
全文:
作者简介
Tatyana Adasheva
Russian University of Medicine of the Ministry of Healthcare of Russia
编辑信件的主要联系方式.
Email: adashtv@mail.ru
ORCID iD: 0000-0002-3763-8994
MD, Dr. Sci (Medicine), professor, professor of the Department of therapy and preventive medicine
俄罗斯联邦, MoscowEkaterina Gubernatorova
Russian University of Medicine of the Ministry of Healthcare of Russia
Email: creativeone@list.ru
ORCID iD: 0009-0009-4149-9497
MD, PhD (Medicine), assistant at the Department of therapy and preventive medicine
俄罗斯联邦, MoscowValeria Boltikova
Russian University of Medicine of the Ministry of Healthcare of Russia
Email: vboltikova00@mail.ru
ORCID iD: 0009-0007-0237-884X
MD, resident of the Department of therapy and preventive medicine
俄罗斯联邦, MoscowLeili Akhmedyarova
Reaviz Medical University; Hospital of Centrosoyuz of the Russian Federation
Email: ahleyli@gmail.com
ORCID iD: 0000-0002-7640-6352
MD, PhD (Medicine), associate professor of the Department of internal medicine, head of the Department of therapy
俄罗斯联邦, Moscow; MoscowKamila Bagatyrova
Russian University of Medicine of the Ministry of Healthcare of Russia
Email: akamila1981@yandex.ru
ORCID iD: 0000-0002-2529-3167
MD, PhD (Medicine), associate professor of the Department of therapy and preventive medicine
俄罗斯联邦, Moscow参考
- Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314(17):1818–31. PMID: 26529160. PMCID: PMC4752169. https://doi.org/10.1001/jama.2015.13766
- Де В.А., Загородникова К.А., Иващенко Д.В., Киселев Ю.Ю., Клейменова Е.Б., Клепикова М.В. с соавт. Лекарственно-индуцированные заболевания. Том I. Коллективная монография. М.: Прометей. 2022; 540 с. [Dyo VA, Zagorodnikova KA, Ivashchenko DV, Kiselev YuYu, Kleimenova EB, Klepikova MV et al. Drug-induced diseases. Volume I. Collective monograph. Moscow: Prometey. 2022; 540 pp. (In Russ.)]. ISBN: 978-5-00172-269-4. EDN: HICFSZ.
- Зотова И.В., Затейщиков Д.А. Наследственная тромбофилия и венозные тромбоэмболические осложнения: правила тестирования в клинической практике. Российский кардиологический журнал. 2020;25(S3):55–61. [Zotova IV, Zateyshchikov DA. Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020;25(S3):55–61 (In Russ.)]. EDN: EBRAJO. https://doi.org/10.15829/1560-4071-2020-4024
- Небыльцова О.В., Климова Ж.А., Носенко Г.А. Лабораторный справочник СИНЭВО. К.: ООО «Доктор2Медиа». 2013; 644 с. [Nebyltsova OV, Klimova ZhA, Nosenko GA. SYNEVO laboratory reference book. Kiev: Doctor2Media LLC. 2013;644 pp (In Russ.)]. ISBN: 978-966-2165-55-5.
- Золотов С.О., Пушкарева И.Н. Методика развития силовых способностей бодибилдеров юниоров. Электронная библиотека УрГПУ. 2017. Доступ: https://elar.uspu.ru/handle/ru-uspu/57020 (дата обращения – 09.10.2025). [Zolotov SO, Pushkareva IN. Methodology for developing strength abilities of junior bodybuilders. Ural State Pedagogical University Electronic Library. 2017. URL: https://elar.uspu.ru/handle/ru-uspu/57020 (date of access – 09.10.2025) (In Russ.)].
- Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451–57. PMID: 16339333. https://doi.org/10.1093/gerona/60.11.1451
- Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: Recommendations for a standardized monitoring plan. J Androl. 2003;24(3):299–311. PMID: 12721204. https://doi.org/10.1002/j.1939-4640.2003.tb02676.x
- Ефремов Е.А. Красняк С.С. Возможные риски при терапии тестостероном. Экспериментальная и клиническая урология. 2017;(1):90–97. [Efremov EA, Krasnyak SS. Potential risks of testostetone replacement therapy. Eksperimental’naya i klinicheskaya urologiya = Experimental and Clinical Urology. 2017;(1):90–97 (In Russ.)]. EDN: ZEHPGR.
- Клинические рекомендации. Рак предстательной железы. Ассоциация онкологов России, общероссийская общественная организация «Российское общество онкоурологов», общероссийская общественная организация «Российское общество клинической онкологии», общероссийская общественная организация «Российское общество урологов». Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 12_3. Доступ: https://cr.minzdrav.gov.ru/preview-cr/12_3 (дата обращения – 09.10.2025). [Clinical guidelines. Prostate cancer. Association of Oncologists of Russia, Russian Society of Oncourologists, Russian Society of Clinical Oncology, Russian Society of Urologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 12_3. URL: https://cr.minzdrav.gov.ru/preview-cr/12_3 (date of access – 09.10.2025) (In Russ.)].
- Клинические рекомендации. Хроническая болезнь почек. Национальная Ассоциация нефрологов. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 469_3. Доступ: https://cr.minzdrav.gov.ru/preview-cr/469_3 (дата обращения – 09.10.2025). [Clinical guidelines. Chronic kidney disease. National Association of Nephrologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2024. ID: 469_3. URL: https://cr.minzdrav.gov.ru/preview-cr/469_3 (date of access – 09.10.2025) (In Russ.)].
- Магомедалиев М.О., Корабельников Д.И., Хорошилов С.Е. Прогностическое значение цистатина-С как предиктора развития острого повреждения почек при COVID-19. Общая реаниматология. 2023;19(2):14–22. [Magomedaliev MO, Korabelnikov DI, Khoroshilov SE. Prognostic value of cystatin-C as a predictor of the development of acute kidney injury in COVID-19. Obshchaya reanimatologiya = General Reanimatology. 2023;19(2):14–22 (In Russ.)]. EDN: KQNWSI. https://doi.org/10.15360/1813-9779-2023-2-2243
- Cho E, Choi SJ, Kang DH, Kalantar-Zadeh K, Ko GJ. Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders. Curr Opin Nephrol Hypertens. 2022;31(1):18–25. PMID: 34846311. https://doi.org/10.1097/MNH.0000000000000755
补充文件







